Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-26

Clinical Trial Update: Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of eliglustat in Chinese pediatric patients with Gaucher disease types 1 and 3; the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eliglustat (Eliglustat)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Gaucher Disease | Phase 2 | Status: NOT_YET_RECRUITING